Clinical Trial Update: Patient-individualized Peptide Vaccination Based on Tumor-specific Mutations in Children and Young Adults With Primary/Relapsed ALL [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial investigated patient-individualized peptide vaccination targeting tumor-specific mutations in children and young adults with primary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: University Children's Hospital Tuebingen | Conditions: Primary/Relapsed Acute Lymphoblastic Leukemia (ALL) of Childhood, Adolescents and Young Adults | Phase 1, Phase 2 | Status: COMPLETED